Captor Therapeutics S.A. (CTX) — Strategic Asset Allocation Index
Captor Therapeutics S.A. (CTX) has a Strategic Asset Allocation Index of 15.6% as of June 2023. Strategic assets (PP&E of zł8.69 Million plus long-term investments of zł-) total zł8.69 Million, measured against net assets of zł55.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CTX net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Captor Therapeutics S.A. Strategic Asset Allocation Index (2021–2021)
This chart shows how Captor Therapeutics S.A.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 15.6%, representing strategic assets of zł8.69 Million against net assets of zł55.52 Million PLN. For live market cap and overall valuation, see market cap of Captor Therapeutics S.A..
Annual Strategic Asset Allocation Index for Captor Therapeutics S.A. (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Captor Therapeutics S.A. from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CTX book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 10.2% | zł12.61 Million | zł12.61 Million | zł- | zł124.20 Million | — |